Immunovant, Inc.
New York, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Immunovant, Inc was founded by Christopher Van Tuyl, Michael Geffner, Andrew Fromkin, Atul Pande, George Migausky, Eric Venker, Frank Torti, Pete Salzmann, Jay Stout, Melanie Gloria, Eva Renee Barnett, Bill Macias and Douglas Hughes, and is based in New York, United States.
Key facts
- Industry
- Pharmaceuticals
- Legal form
- Incorporated in Delaware
- Listed
- Nasdaq · IMVT
About
Biological Products, (No Diagnostic Substances); formerly Health Sciences Acquisitions Corp; listed on Nasdaq as IMVT; filing with the SEC since 2019
Founders
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 687 other pharmaceuticals companies. None has a closure on record yet. Of the 638 that report what they raised, the median is $4,127,748.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment